Affirm Holdings, Inc.
Robert O'Hare (Chief Financial Officer) sells AFRM shares
About this filing
Affirm Holdings, Inc. (AFRM) filed Form 4 (insider transaction) with the SEC on Oct 14, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Robert O'Hare · Chief Financial Officer
Rule 10b5-1 plan · adopted May 21, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 9, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +17,023 | $17.19 | $292,625.37 | 19,757 | Direct |
| Oct 9, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +1,866 | $41.80 | $77,998.80 | 21,623 | Direct |
| Oct 9, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +10,239 | $22.30 | $228,329.70 | 31,862 | Direct |
| Oct 9, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +21,836 | $23.35 | $509,870.60 | 53,698 | Direct |
| Oct 9, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +8,991 | $44.06 | $396,143.46 | 62,689 | Direct |
| Oct 9, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +5,636 | $57.59 | $324,577.24 | 68,325 | Direct |
| Oct 9, 2026 | S · open-market saleFootnotes F1, F2 | −65,591 | $80.02 | $5,248,591.82 | 2,734 | Direct |
| Oct 9, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F3 | −1,866 | $0.00 | $0.00 | 0 | Direct |
| Oct 9, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F4 | −17,023 | $0.00 | $0.00 | 0 | Direct |
| Oct 9, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F5 | −10,239 | $0.00 | $0.00 | 0 | Direct |
| Oct 9, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F6 | −21,836 | $0.00 | $0.00 | 26,690 | Direct |
| Oct 9, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F7 | −8,991 | $0.00 | $0.00 | 22,978 | Direct |
| Oct 9, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F8 | −5,636 | $0.00 | $0.00 | 15,658 | Direct |
Footnotes
- F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026.
- F2 Represents the weighted average sale price of the shares sold from $80.00 to $80.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3 The stock options vest in 48 equal monthly installments beginning April 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
- F4 The stock options vest in 48 equal monthly installments beginning August 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
- F5 The stock options vest in 48 equal monthly installments beginning October 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
- F6 The stock options vest as to 25% of the underlying shares on September 1, 2024 and the remainder vest in 36 equal monthly installments over the subsequent three years subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
- F7 The stock options vest as to 25% of the underlying shares on September 1, 2025 and the remainder vest in 36 equal monthly installments over the subsequent three years subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
- F8 The stock options vest in 48 equal monthly installments beginning December 1, 2024, subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
More AFRM filings
- 4
Filed Nov 3, 2026
- DEFA14A
Filed Oct 23, 2026
- DEF 14A
Filed Oct 23, 2026
- ARS
Filed Oct 23, 2026
- 144
Filed Oct 9, 2026
- 4
Filed Sep 18, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.